1 min read
Orthofix Q3 Revenue Misses Estimates by $2.62 Million as EPS Beats
Revenue rose 1.1% year over year. Cash, cash equivalents and restricted cash fell to $86.9 million at Sept. 30 from $104.4 million at June 30.

Orthofix Medical Inc. (OFIX) posted third-quarter revenue of $207.9 million, missing estimates by $2.62 million, while its GAAP loss per share was 12 cents better than expected.
Revenue rose 1.1% from a year earlier. The company recorded a GAAP loss of $0.15 per share.
Cash, cash equivalents and restricted cash totaled $86.9 million on Sept. 30, compared with $104.4 million on June 30. The sequential decrease primarily reflected working-capital timing.